Clinical Trial Update: Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial of itraconazole in castration-resistant prostate cancer after chemotherapy was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

Sponsor: Stanford University | Conditions: Prostate Cancer, Prostatic Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2014-09-08